Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Removed the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' related topics from the page. This reduces cross-linking to disease-specific topics and genetics resources on the study record.
    Difference
    0.0%
    Check dated 2025-12-31T00:57:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The Study Details page now lists hundreds of new locations across multiple regions and adds related topics such as MedlinePlus Genetics. Recruitment-related information and contact details were updated.
    Difference
    7%
    Check dated 2025-12-23T21:55:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    MagnetisMM-7 (NCT05317416) recruitment status updated to Active, not recruiting as of 2025-12-15, replacing the prior Recruiting status. Enrollment is not open at listed sites.
    Difference
    0.2%
    Check dated 2025-12-16T21:20:44.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    New study site added: Wroclaw, Poland (52-007). Recruitment status updated to Active, not recruiting as of 2025-12-04.
    Difference
    0.4%
    Check dated 2025-12-09T19:24:23.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The study's recruitment locations have been updated to 217, with the removal of O'Brien Pharmacy (Mission, KS) and American Oncology Partners dba MidAmerica Cancer Care (Merriam, KS). Related topics now include Multiple Myeloma and MedlinePlus Genetics.
    Difference
    0.7%
    Check dated 2025-11-25T12:01:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Study record status updated to Active, not recruiting. Revision dates 2025-11-11 and 2025-11-13 were added to the page history.
    Difference
    0.3%
    Check dated 2025-11-18T07:23:16.000Z thumbnail image

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.